<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Liehr T</submitter><funding>State Committee of the Republic of Armenia</funding><pagination>2816</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC9689121</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>12(11)</volume><pubmed_abstract>In the short 10 years following the introduction of non-invasive prenatal testing (NIPT), it has been adapted in many countries around the world as a standard screening test. In this review, this development was analyzed with a special focus on Germany. As a result, it can be stated that all known advantages of NIPT apart from "compensating for having no access to centers offering invasive diagnostics" are valid for Germany. In addition, following a review of the international literature, all documented issues with NIPT are also observed in Germany. However, the German Gene Diagnostics Act (GenDG) addresses a number of these issues, for example, the regulations by GenDG hamper induced abortions, based exclusively on an abnormal NIPT result. At the same time, GenDG has created new problems,</pubmed_abstract><journal>Diagnostics (Basel, Switzerland)</journal><pubmed_title>Non-Invasive Prenatal Testing in Germany.</pubmed_title><pmcid>PMC9689121</pmcid><funding_grant_id>SC RA #21AG-1F068</funding_grant_id><pubmed_authors>Liehr T</pubmed_authors><pubmed_authors>Williams H</pubmed_authors><pubmed_authors>Harutyunyan T</pubmed_authors><pubmed_authors>Weise A</pubmed_authors></additional><is_claimable>false</is_claimable><name>Non-Invasive Prenatal Testing in Germany.</name><description>In the short 10 years following the introduction of non-invasive prenatal testing (NIPT), it has been adapted in many countries around the world as a standard screening test. In this review, this development was analyzed with a special focus on Germany. As a result, it can be stated that all known advantages of NIPT apart from "compensating for having no access to centers offering invasive diagnostics" are valid for Germany. In addition, following a review of the international literature, all documented issues with NIPT are also observed in Germany. However, the German Gene Diagnostics Act (GenDG) addresses a number of these issues, for example, the regulations by GenDG hamper induced abortions, based exclusively on an abnormal NIPT result. At the same time, GenDG has created new problems,</description><dates><release>2022-01-01T00:00:00Z</release><publication>2022 Nov</publication><modification>2025-04-19T00:35:39.122Z</modification><creation>2025-04-07T11:40:17.869Z</creation></dates><accession>S-EPMC9689121</accession><cross_references><pubmed>36428876</pubmed><doi>10.3390/diagnostics12112816</doi></cross_references></HashMap>